Get the Stockscreener App
0.3684
0.43%
-0.0016
After Hours:
.38
0.0116
+3.15%
Vyne Therapeutics Inc stock is traded at $0.3684, with a volume of 2.39M.
It is down -0.43% in the last 24 hours and up +18.65% over the past month.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
See More
Previous Close:
$0.37
Open:
$0.355
24h Volume:
2.39M
Relative Volume:
0.88
Market Cap:
$9.38M
Revenue:
$486.00K
Net Income/Loss:
$-28.43M
P/E Ratio:
-0.1307
EPS:
-2.8189
Net Cash Flow:
$-26.75M
1W Performance:
+2.25%
1M Performance:
+18.65%
6M Performance:
-76.31%
1Y Performance:
-80.71%
1-Day Range:
$0.355
$0.385
1-Week Range:
$0.3487
$0.4565
52-Week Range:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Name
Vyne Therapeutics Inc
Sector
Industry
Phone
800-775-7936
Address
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3684 | 9.42M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-18-24 | Initiated | BTIG Research | Buy |
| Dec-06-21 | Resumed | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Stock (VYNE) Latest News
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice - MSN
Will VYNE Therapeutics Inc. stock benefit from sector rotationJuly 2025 Weekly Recap & Fast Exit/Entry Strategy Plans - newser.com
Forecasting VYNE Therapeutics Inc. price range with options dataWatch List & Fast Gaining Stock Strategy Reports - newser.com
Why VYNE Therapeutics Inc. stock could be next big winner2025 Investor Takeaways & Community Consensus Picks - newser.com
Applying Elliott Wave Theory to VYNE Therapeutics Inc.2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
EOM Pharmaceutical (OTCMKTS:IMUC) vs. VYNE Therapeutics (NASDAQ:VYNE) Critical Survey - Defense World
Will VYNE Therapeutics Inc. see short term momentumJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Will VYNE Therapeutics Inc. stock split again soonGlobal Markets & Community Shared Stock Ideas - newser.com
Can machine learning forecast VYNE Therapeutics Inc. recoveryWeekly Gains Report & Real-Time Volume Analysis - newser.com
VYNE Therapeutics Inc. stock trendline breakdown2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Using Ichimoku Cloud for VYNE Therapeutics Inc. technicals2025 Market Trends & Safe Swing Trade Setups - newser.com
What candlestick patterns are forming on VYNE Therapeutics Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Intraday pattern recognizer results for VYNE Therapeutics Inc.Buy Signal & Low Risk High Reward Ideas - newser.com
What analysts say about VYNE Therapeutics Inc stockAI-Driven Market Analysis & Superior Capital Trading Plans - earlytimes.in
Will VYNE Therapeutics Inc. outperform the marketWeekly Volume Report & AI Driven Price Predictions - newser.com
Will VYNE Therapeutics Inc. bounce back from current supportBond Market & Daily Growth Stock Tips - newser.com
Exit strategy if you’re trapped in VYNE Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Is VYNE Therapeutics Inc a good long term investmentTake Profit Strategies & Low Risk Trading Growth - earlytimes.in
Sentiment analysis tools applied to VYNE Therapeutics Inc.2025 Sector Review & Safe Entry Zone Tips - newser.com
How high can VYNE Therapeutics Inc. stock goWeekly Investment Recap & Weekly Top Stock Performers List - newser.com
Market reaction to VYNE Therapeutics Inc.’s recent news2025 Market Overview & Daily Price Action Insights - newser.com
Vyne Therapeutics Inc Stock (VYNE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):